Life Sciences Real Estate

What Life Sciences Real Estate does

Life Sciences Real Estate is a subscription-based market intelligence platform dedicated to the European life sciences real estate sector, founded in 2022 by Stephen Ryan, an independent real estate researcher and CFA charterholder. The company publishes a bi-weekly newsletter covering deals, market analysis, and featured European locations, and operates a proprietary searchable and filterable deals database containing over 1,400 verified transactions (referenced in some materials as 1,600+) spanning more than 26 million square metres of space across multiple European countries. Database records are standardized on location, deal type, value, size, lease terms, parties, and date, and are constructed through a combination of newsletter capture and systematic historical research including data mining, fieldwork, and expert interviews.

The platform monetizes through a three-tier membership model: a free tier offering previews and limited content, a Subscriber tier priced at €125/month or €399/year providing full article and newsletter access for three company seats, and a Premium tier at €2,499/year (a 45% discount from a €4,499 list price) that adds the deals database, future tools, and five seats. Target customers are institutional investors, fund managers, REITs, developers, occupiers, and advisers in the life sciences property ecosystem. Named subscribers visible on the homepage include CBRE, JLL, Kadans Science Partner, Oxford Properties, Physicus, and William Fry.

Operationally, the company is a small, founder-led, digital-first research firm. Beyond Stephen Ryan, the disclosed team includes Finance Director Monika Sosnowska (a qualified accountant specializing in European commercial property) and Contributing Author Maurizio Grilli (a strategist with 25+ years of real estate advisory experience and a Henley Business School lecturer). The company is privately held with no external institutional funding, no parent company, and no disclosed revenue, and is positioned as the leading specialized data provider addressing a documented transparency gap in a multi-billion-euro European niche that historically lacked established data coverage.

Name

Life Sciences Real Estate

Legal name

Life Sciences Real Estate

Website

https://lifesciencesrealestate.org

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Life Sciences Real Estate is a subscription-based market intelligence platform providing a bi-weekly newsletter and a searchable database of 1,400+ verified European life sciences real estate transactions, serving investors, developers, occupiers, and advisers across Europe.

Ownership category

akta.pro rank

Product category

Commercial Real Estate Intelligence

NAICS

Real Estate Property Managers (53131), Portfolio Management and Investment Advice (523940)

SIC

Real Estate (6500)

akta.pro primary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

akta.pro secondary industries

Life Sciences/Laboratory Property Management (BPAJAGAL), Specialty Real Assets / Niche Strategies (Marinas, Student Housing, Self-Storage, Life Science RE) (FSANAEAO)

Keywords

• Commercial real estate intelligence
• Life sciences property data
• Real estate market research
• Property transactions database
• Commercial property analytics

Headquarters

HQ city

Dublin

HQ country

Ireland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Subscription Revenue: Three-tier subscription model: (1) Free tier with limited content access, (2) Subscriber tier at €125/month or €399/year offering full article and newsletter access with three company seats, (3) Premium tier at €2,499/year adding deals database access, future tools, and five company seats.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Life Sciences Real Estate is a subscription-based market intelligence platform dedicated to European life sciences real estate. It delivers a bi-weekly newsletter with deal analysis and market commentary, a proprietary searchable deals database tracking 1,400+ verified transactions across more than 26 million square metres, and curated featured-location deep-dives on key European clusters.

Product overview

Life Sciences Real Estate is a market intelligence platform for European life sciences real estate, offering a unified service comprising a bi-weekly newsletter (Life Sciences Real Estate), a searchable deals database with over 1,400 verified transactions, and curated featured location articles covering key European markets. The platform operates on a tiered membership model: Free (previews and limited content), Subscriber (€399/year for full content access), and Premium (€2,499/year adding database and tool access). The newsletter and database are integrated offerings within the same platform, with historic deal research supplementing recent transaction coverage.

Differentiator

Problem solved

Functional benefit

Products and services

• Life Sciences Real Estate Newsletter A bi-weekly newsletter providing market intelligence, deal tracking, and analysis of European life sciences real estate transactions and trends, intended for investors, developers, occupiers, and advisers.
• Deals Database A searchable and filterable database containing over 1,400 verified life sciences real estate transactions across Europe, filterable by location, deal type, value, size, date, and lead entity, available to Premium subscribers.
• Featured Locations In-depth articles profiling key European life sciences real estate markets, including Vienna, Switzerland, Warsaw, Bristol, Portugal, Manchester, and other hubs, providing cluster-level market context.

Named customers6 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Six partnerships are on record, tiered minor.

• CBREminorOthersListed as subscriber/logo on Life Sciences Real Estate homepage. CBRE subscribes to the newsletter for market intelligence on European life sciences real estate.
• JLLminorOthersListed as subscriber/logo on Life Sciences Real Estate homepage. JLL subscribes to the newsletter for market intelligence on European life sciences real estate.
• Kadans Science PartnerminorOthersListed as subscriber/logo on Life Sciences Real Estate homepage. Kadans subscribes to the newsletter for market intelligence.
• Oxford PropertiesminorOthersListed as subscriber/logo on Life Sciences Real Estate homepage. Oxford Properties subscribes to the newsletter for market intelligence.
• PhysicusminorOthersListed as subscriber/logo on Life Sciences Real Estate homepage. Physicus subscribes to the newsletter for market intelligence.
• William FryminorOthersListed as subscriber/logo on Life Sciences Real Estate homepage. William Fry subscribes to the newsletter for market intelligence.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Market position

Strengths4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/life-sciences-real-estate

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Life Sciences Real Estate